Скачать с ютуб CTF Webinar: GENE THERAPY IN NF в хорошем качестве

CTF Webinar: GENE THERAPY IN NF

The Children's Tumor Foundation presented this webinar on the opportunities and challenges in gene therapy in neurofibromatosis, or NF. This webinar was recorded live on May 12, 2020 and included the following speakers: Peter Marks, MD, PhD, Director, Center for Biologics Evaluation and Research (CBER) @U.S. Food and Drug Administration (FDA) Scott Plotkin, MD, PhD, Massachusetts General Hospital and Chair, CTF Clinical Advisory Board Peggy Wallace, PhD, University of Florida College of Medicine and Past Chair, CTF Research Advisory Board Simon Vukelj, Chief Marketing Officer, Children's Tumor Foundation Annette Bakker, PhD, Children's Tumor Foundation To enable closed captioning, click the CC button. What is the Children's Tumor Foundation? Children’s Tumor Foundation (CTF) began as the first grassroots organization solely dedicated to finding treatments for NF. Today, CTF is a highly recognized global nonprofit foundation, the leading force in the fight to end NF, and a model for other innovative research endeavors. Visit our website at https://www.ctf.org/ Donate today at https://www.ctf.org/ways-to-give/ Follow us on our social media platforms: Facebook -   / childrenstumor   Instagram -   / childrenstumor   Twitter -   / childrenstumor   LinkedIn -   / children's-tumor-foundation   #endnf #nf1 #nf2 #nf2swn #swn #childrenstumor #neurofibromatosis #schwannomatosis #nervetumor #tumor